SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Encision Inc. (ECIA) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ECIA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.33
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.02
Book Value / Share$0.00
Revenue / Share$0.55
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.08 |
$9.34M |
$-880K |
-9.4% |
| 2017 |
$-0.07 |
$8.87M |
$-729K |
-8.2% |
| 2018 |
$0.03 |
$8.75M |
$336K |
3.8% |
| 2019 |
$-0.02 |
$8.8M |
$-236.1K |
-2.7% |
| 2020 |
$-0.02 |
$7.67M |
$-241.43K |
-3.1% |
| 2021 |
$0.05 |
$7.54M |
$584.73K |
7.8% |
| 2022 |
$0.04 |
$7.67M |
$463.34K |
6% |
| 2023 |
$-0.03 |
$7.35M |
$-366K |
-5% |
| 2024 |
$-0.06 |
$6.59M |
$-691.78K |
-10.5% |
| 2025 |
$-0.02 |
$6.56M |
$-220.2K |
-3.4% |
